{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:21:28Z","timestamp":1790014888183,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.eururo.2007.10.013","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T11:21:12Z","timestamp":1192620072000},"page":"275-287","source":"Crossref","is-referenced-by-count":236,"title":["Botulinum Toxin A (Botox\u00ae) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity\/Neurogenic Overactive Bladder: A Systematic Literature Review"],"prefix":"10.1016","volume":"53","author":[{"given":"Gilles","family":"Karsenty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Denys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Amarenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"De Seze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Gam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Haab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Kerdraon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Perrouin-Verbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Ruffion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Saussine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schurch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chartier-Kastler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2007.10.013_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.10.013_bib2","first-page":"1","article-title":"Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus","volume":"26","author":"van Ermengem","year":"1897","journal-title":"Zeitsch Hyg Infekt"},{"key":"10.1016\/j.eururo.2007.10.013_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1017\/S0033583500003292","article-title":"Structure and function of tetanus and botulinum neurotoxins","volume":"28","author":"Montecucco","year":"1995","journal-title":"Q Rev Biophys"},{"key":"10.1016\/j.eururo.2007.10.013_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2006.01.005","article-title":"Botulinum toxin\u2014new mechanisms, new therapeutic directions?","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib5","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.eururo.2007.10.013_bib6","first-page":"401","article-title":"Botulinum A toxin in the treatment of detrusor hyperreflexia in spinal cord injury. A new alternative to medical and surgical procedures?","volume":"18","author":"Stohrer","year":"1999","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2007.10.013_bib7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","article-title":"Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results","volume":"50","author":"Patel","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2007.06575.x","article-title":"Botulinum toxin A in the overactive bladder: current status and future directions","volume":"99","author":"Dmochowski","year":"2007","journal-title":"BJU Int"},{"issue":"Suppl 4","key":"10.1016\/j.eururo.2007.10.013_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1468-1331.2006.01649.x","article-title":"Using translational medicine to understand clinical differences between botulinum toxin formulations","volume":"13","author":"Aoki","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.eururo.2007.10.013_bib10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2133.2003.05620.x","article-title":"A double-blind, randomized, comparative study of Dysport\u00ae vs. Botox\u00ae in primary palmar hyperhidrosis","volume":"149","author":"Simonetta Moreau","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.eururo.2007.10.013_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2710.2007.00835.x","article-title":"Comparing two botulinum toxin type A formulations using manufacturers\u2019 product summaries","volume":"32","author":"Wenzel","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.eururo.2007.10.013_bib12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.clinthera.2007.07.020","article-title":"Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia","volume":"29","author":"Chapman","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.eururo.2007.10.013_bib13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2165\/00003495-200666100-00001","article-title":"Botulinum toxin for the management of bladder dysfunction","volume":"66","author":"Schurch","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.eururo.2007.10.013_bib14","first-page":"198","article-title":"Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art","volume":"8","author":"Nitti","year":"2006","journal-title":"Rev Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ucl.2004.09.005","article-title":"Injectable neuromodulatory agents: botulinum toxin therapy","volume":"32","author":"Frenkl","year":"2005","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.eururo.2007.10.013_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1185\/030079906X104614","article-title":"Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies","volume":"22","author":"Denys","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.eururo.2007.10.013_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib18","first-page":"79","article-title":"New therapeutic options for refractory neurogenic detrusor overactivity","volume":"56","author":"Giannantoni","year":"2004","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.eururo.2007.10.013_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","article-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Karsenty","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.10.013_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","article-title":"Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis","volume":"25","author":"Schulte-Baukloh","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2007.10.013_bib22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","article-title":"Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib23","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0022-5347(06)00258-8","article-title":"Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity","volume":"175","author":"Giannantoni","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.urology.2005.08.016","article-title":"Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions","volume":"67","author":"Kuo","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.10.013_bib25","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.eururo.2007.10.013_bib26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2007.10.013_bib28","first-page":"2543","article-title":"Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: initial results","volume":"12","author":"Hajebrahimi","year":"2005","journal-title":"Can J Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.10.013_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00365590410015867","article-title":"Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions","volume":"38","author":"Bagi","year":"2004","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2007.10.013_bib31","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2007.10.013_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","article-title":"A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity","volume":"92","author":"Harper","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2007.10.013_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1310\/1640-XEPP-Y33E-TMK8","article-title":"Botulinum-A toxin injections as a treatment for refractory detrusor hyperreflexia","volume":"8","author":"Kennelly","year":"2003","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"10.1016\/j.eururo.2007.10.013_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2007.10.013_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/01952307.1985.11785932","article-title":"Urodynamics and management of the neuropathic bladder in spinal cord injury patients","volume":"8","author":"McGuire","year":"1985","journal-title":"J Am Paraplegia Soc"},{"key":"10.1016\/j.eururo.2007.10.013_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1569-9056(07)60885-9","article-title":"Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI)\u2014a prospective randomized study to compare 30 vs. 10 injection sites","volume":"6","author":"Karsenty","year":"2007","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2007.10.013_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sc.1995.131","article-title":"Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance","volume":"33","author":"Perrouin-Verbe","year":"1995","journal-title":"Paraplegia"},{"key":"10.1016\/j.eururo.2007.10.013_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.sc.3101736","article-title":"Adverse events after botulinum A toxin injection for neurogenic voiding disorders","volume":"43","author":"De Laet","year":"2005","journal-title":"Spinal Cord"},{"key":"10.1016\/j.eururo.2007.10.013_bib39","first-page":"387","article-title":"Effectiveness of periurethral botulinum toxin injection in the treatment of voiding dysfunction due to detrusor underactivity and non-relaxing urethra","volume":"21","author":"Kuo","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2007.10.013_bib40","first-page":"522","article-title":"Botulinum-A toxin in the treatment of detrusor hyperreflexia","volume":"20","author":"Del Popolo","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2007.10.013_bib41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.sc.3101318","article-title":"Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity","volume":"40","author":"Wyndaele","year":"2002","journal-title":"Spinal Cord"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380701264X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380701264X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T12:20:45Z","timestamp":1546518045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228380701264X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S030228380701264X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2007.10.013","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}